Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiepileptic Efficacy and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05697614
What this trial is testing

The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children

Who this might be right for
Drug Resistant Epilepsy
Dr Cipto Mangunkusumo General Hospital 100
Large-scale testing (Phase 3)Study completedNCT01292837
What this trial is testing

Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Who this might be right for
EpilepsyGeneralized Tonic-clonic Seizures
UCB Japan Co. Ltd. 13
Large-scale testing (Phase 3)Study completedNCT00175903
What this trial is testing

Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy

Who this might be right for
Epilepsy
UCB Pharma 1,701
Large-scale testing (Phase 3)Study completedNCT00603473
What this trial is testing

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 92
Post-approval studies (Phase 4)Study completedNCT01630057
What this trial is testing

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

Who this might be right for
Partial Seizures
Eisai Inc. 200
Large-scale testing (Phase 3)Study completedNCT00433667
What this trial is testing

The Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Who this might be right for
EpilepsyEpilepsy, FocalSeizure Disorder+2 more
SK Life Science, Inc. 563
Not applicableNot Yet RecruitingNCT07535736
What this trial is testing

Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury

Who this might be right for
Antiepileptic Efficacy and SafetyBrain Injuries
Assiut University 70
Testing effectiveness (Phase 2)WithdrawnNCT05757544
What this trial is testing

Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)

Who this might be right for
Status Epilepticus
Marinus Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Large-scale testing (Phase 3)Study completedNCT02408523
What this trial is testing

Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 242
Large-scale testing (Phase 3)Study completedNCT00266591
What this trial is testing

The Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Testing effectiveness (Phase 2)Study completedNCT00210522
What this trial is testing

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 421
Testing effectiveness (Phase 2)Study completedNCT03650452
What this trial is testing

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
Takeda 141
Large-scale testing (Phase 3)Study completedNCT00235755
What this trial is testing

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

Who this might be right for
Seizures
GlaxoSmithKline 539
Testing effectiveness (Phase 2)Ended earlyNCT00290771
What this trial is testing

Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Recurrent Glioblastoma Multiforme (GBM)
Novartis 231
Large-scale testing (Phase 3)Study completedNCT01063764
What this trial is testing

An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures

Who this might be right for
EpilepsyPartial Seizures
UCB Japan Co. Ltd. 73
Large-scale testing (Phase 3)WithdrawnNCT05814523
What this trial is testing

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Who this might be right for
Refractory Status Epilepticus
Marinus Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT00982787
What this trial is testing

Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy

Who this might be right for
Partial Epilepsy
Oregon Health and Science University
Large-scale testing (Phase 3)Study completedNCT00866775
What this trial is testing

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Who this might be right for
Epilepsy With Simple or Complex Partial Onset Seizures
Sumitomo Pharma America, Inc. 193
Large-scale testing (Phase 3)Study completedNCT02091375
What this trial is testing

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 120
Next Page